Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden death

被引:90
作者
Krahn, AD
Connolly, SJ
Roberts, RS
Tech, M
Gent, M
机构
[1] Univ Western Ontario, London Hlth Sci Ctr, Div Cardiol, London, ON N6A 5A5, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] McMaster Univ, Div Cardiol, Hamilton, ON, Canada
关键词
D O I
10.1016/j.ahj.2003.12.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Advances in primary and secondary prevention of sudden death have led to a wide array of potentially beneficial therapies. Identification of patients most likely to benefit would be of use when considering costly interventions such as an implantable defibrillator. We sought to determine the effect of advancing age on the mode of death in the Amiodarone Trialists Metanalysis. Methods and Results Patients (n = 6252; age, 61.2 +/- 10.5 years; 83% men) were included in an analysis of predictors of sudden death (SD) and all-cause death (ACD), based on baseline variables at enrollment. Patients were divided into 5 age groups: :! 50 years, 5 1 to 60 years, 61 to 70 years, 71 to 80 years, and >80 years. During a mean of 16.8 +/- 10.3 months of follow-up, there were 1023 deaths, with an annual overall mortality rate of 11.7%. Both sudden death and nonsudden death rates increased with age, although the increase of nonsudden death with age was more dramatic. The overall proportion of death that was sudden (SD/ACD ratio) was 0.41, falling from 0.51 before age 50 years to 0.26 after age 80 years (P = .002 for trend). The SD/ACD ratio was not affected by sex, New York Heart Association Class, or left ventricular ejection fraction. Conclusions Although the incidence of sudden death increases with age, the proportion of death that is sudden diminishes markedly. This finding may influence the yield of interventions targeted at prevention of sudden death.
引用
收藏
页码:837 / 840
页数:4
相关论文
共 24 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS, P131
[2]   EFFECT OF ANTIARRHYTHMIC THERAPY ON MORTALITY IN SURVIVORS OF MYOCARDIAL-INFARCTION WITH ASYMPTOMATIC COMPLEX VENTRICULAR ARRHYTHMIAS - BASEL ANTIARRHYTHMIC STUDY OF INFARCT SURVIVAL (BASIS) [J].
BURKART, F ;
PFISTERER, M ;
KIOWSKI, W ;
FOLLATH, F ;
BURCKHARDT, D ;
JORDI, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (07) :1711-1718
[3]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[4]   Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death [J].
Buxton, AE ;
Lee, KL ;
DiCarlo, L ;
Gold, MR ;
Greer, GS ;
Prystowsky, EN ;
O'Toole, MF ;
Tang, A ;
Fisher, JD ;
Coromilas, J ;
Talajic, M ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) :1937-1945
[5]   Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT [J].
Cairns, JA ;
Connolly, SJ ;
Roberts, R ;
Gent, M .
LANCET, 1997, 349 (9053) :675-682
[6]   POSTMYOCARDIAL INFARCTION MORTALITY IN PATIENTS WITH VENTRICULAR PREMATURE DEPOLARIZATIONS - CANADIAN AMIODARONE MYOCARDIAL-INFARCTION ARRHYTHMIA TRIAL PILOT-STUDY [J].
CAIRNS, JA ;
CONNOLLY, SJ ;
GENT, M ;
ROBERTS, R .
CIRCULATION, 1991, 84 (02) :550-557
[7]   EFFECT OF AMIODARONE ON MORTALITY AFTER MYOCARDIAL-INFARCTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, PILOT-STUDY [J].
CEREMUZYNSKI, L ;
KLECZAR, E ;
KRZEMINSKAPAKULA, M ;
KUCH, J ;
NARTOWICZ, E ;
SMIELAKKOROMBEL, J ;
DYDUSZYNSKI, A ;
MACIEJEWICZ, J ;
ZALESKA, T ;
LAZARCZYKKEDZIA, E ;
MOTYKA, J ;
PACZKOWSKA, B ;
SCZANIECKA, O ;
YUSUF, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (05) :1056-1062
[8]  
Connolly SJ, 1997, LANCET, V350, P1417
[9]   Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone [J].
Connolly, SJ ;
Gent, M ;
Roberts, RS ;
Dorian, P ;
Roy, D ;
Sheldon, RS ;
Mitchell, LB ;
Green, MS ;
Klein, GJ ;
O'Brien, B .
CIRCULATION, 2000, 101 (11) :1297-1302
[10]   RANDOMIZED TRIAL OF LOW-DOSE AMIODARONE IN SEVERE CONGESTIVE-HEART-FAILURE [J].
DOVAL, HC ;
NUL, DR ;
GRANCELLI, HO ;
PERRONE, SV ;
BORTMAN, GR ;
CURIEL, R .
LANCET, 1994, 344 (8921) :493-498